In addition, the link shown by COSMOS between NFKB1 and MYC can have implications for the treatment of ccRCC, due to its pivotal role in arsenite (a drug used in chemotherapy) treatment of cancer (Huang et al, 2014). The gene discussed is NFKB1; the disease is nonpapillary renal cell carcinoma.